[{"data":1,"prerenderedAt":145},["ShallowReactive",2],{"drug-apixaban":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":45,"contraindications":104,"warnings":123,"renal":124,"monitoring":125,"interactions":126,"review":127,"examples":130},"apixaban",1,{"fa":7,"en":8},"آپیکسابان","Apixaban","cardiovascular",{"fa":11,"en":12},"ضدانعقاد خوراکی (مهارکننده فاکتور Xa)","Oral anticoagulant (factor Xa inhibitor)",[14],{"name":15,"market":16},"Eliquis","US",[18,19,7,20,21],"eliquis","الیکوئیس","DOAC","NOAC",[23,37],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":32,"refs":33},"tab-2-5","tablet","oral","2.5 mg tablet",{"amount":29,"unit":30,"perUnit":25,"scored":31},2.5,"mg",false,[16],[34],{"source":35,"section":36},"fda-eliquis","3",{"id":38,"form":25,"route":26,"label":39,"concentration":40,"markets":42,"refs":43},"tab-5","5 mg tablet",{"amount":41,"unit":30,"perUnit":25,"scored":31},5,[16],[44],{"source":35,"section":36},[46,72,94],{"id":47,"disease":48,"label":49,"population":52,"type":56,"unit":30,"dose":57,"refs":59,"notes":62},"af","atrial-fibrillation",{"fa":50,"en":51},"AF غیردریچه‌ای — ۵ mg دو بار در روز","Non-valvular AF — 5 mg twice daily",{"minAge":53},{"value":54,"unit":55},18,"year","fixed",{"perDose":41,"dosesPerDay":58},2,[60],{"source":35,"section":61},"2.1",[63],{"text":64,"refs":67},{"fa":65,"en":66},"اگر حداقل ۲ مورد از سن ≥۸۰، وزن ≤۶۰ kg، کراتینین ≥۱٫۵ وجود دارد: ۲٫۵ mg دو بار. با مهارکننده‌های قوی CYP3A4 و P-gp دوز نصف شود.","If at least 2 of age ≥80, weight ≤60 kg, creatinine ≥1.5: 2.5 mg twice daily. Halve with combined strong CYP3A4 + P-gp inhibitors.",[68,70],{"source":35,"section":69},"2",{"source":35,"section":71},"2.6",{"id":73,"disease":74,"label":75,"population":78,"type":56,"unit":30,"dose":80,"refs":82,"durationDays":84,"notes":86},"vte","venous-thromboembolism",{"fa":76,"en":77},"درمان DVT\u002FPE — ۱۰ mg دو بار ۷ روز، سپس ۵ mg دو بار","DVT\u002FPE treatment — 10 mg twice daily for 7 days, then 5 mg twice daily",{"minAge":79},{"value":54,"unit":55},{"perDose":81,"dosesPerDay":58},10,[83],{"source":35,"section":69},{"min":85,"max":85},7,[87],{"text":88,"refs":91},{"fa":89,"en":90},"پس از ۷ روز: ۵ mg دو بار. پیشگیری از عود پس از ۶ ماه: ۲٫۵ mg دو بار.","After 7 days: 5 mg twice daily. Recurrence prevention after 6 months: 2.5 mg twice daily.",[92,93],{"source":35,"section":69},{"source":35,"section":61},{"id":95,"disease":74,"label":96,"population":99,"type":56,"unit":30,"dose":101,"refs":102},"ortho",{"fa":97,"en":98},"پیشگیری DVT پس از تعویض لگن یا زانو — ۲٫۵ mg دو بار","DVT prophylaxis after hip\u002Fknee replacement — 2.5 mg twice daily",{"minAge":100},{"value":54,"unit":55},{"perDose":29,"dosesPerDay":58},[103],{"source":35,"section":69},[105,114],{"id":106,"severity":107,"text":108,"refs":111},"ci","block",{"fa":109,"en":110},"خونریزی پاتولوژیک فعال؛ حساسیت شدید.","Active pathological bleeding; severe hypersensitivity.",[112],{"source":35,"section":113},"4",{"id":115,"severity":116,"text":117,"refs":120},"boxed","warn",{"fa":118,"en":119},"هشدار جعبه‌ای: قطع زودهنگام خطر ترومبوز را بالا می‌برد؛ هماتوم نخاعی با بی‌حسی نخاعی.","Boxed warning: premature discontinuation raises thrombotic risk; spinal\u002Fepidural haematoma with neuraxial anaesthesia.",[121],{"source":35,"section":122},"Boxed Warning",[],[],[],[],{"status":128,"reviewer":129,"date":129},"unverified",null,[131,136,141],{"regimen":47,"formulation":38,"input":132,"expect":135},{"ageYears":133,"weightKg":134},70,75,{"perDose":41,"perDay":81},{"regimen":73,"formulation":38,"input":137,"expect":140},{"ageYears":138,"weightKg":139},50,80,{"perDose":81,"tabletsPerDoseRounded":58},{"regimen":95,"formulation":24,"input":142,"expect":144},{"ageYears":143,"weightKg":139},65,{"perDose":29},1792078531478]